AGN/PFE/RVNC—Addendum to the bottom paragraph of #msg-118089926: Botox is AGN’s largest and most profitable product by far, so RVNC’s data released today will surely play some role in the PFE-AGN merger discussions, possibly allowing PFE to negotiate a better price.